NASDAQ:BIIB
$300.20
(
-0.731%
)
Friday, 2nd Jun 2023
Biogen Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $291.64 | $319.74 | Friday, 2nd Jun 2023 BIIB stock ended at $300.20. This is 0.731% less than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 1.84% from a day low at $297.68 to a day high of $303.17. |
| 90 days | $254.80 | $319.74 | |
| 52 weeks | $188.54 | $319.74 |
Historical Biogen Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $302.53 | $303.17 | $297.68 | $300.20 | 816 126 |
| 2023-06-01 | $301.02 | $308.25 | $300.19 | $302.41 | 997 382 |
| 2023-05-31 | $298.69 | $299.58 | $294.81 | $296.41 | 1 521 389 |
| 2023-05-30 | $297.92 | $298.95 | $295.51 | $298.69 | 765 526 |
| 2023-05-26 | $298.10 | $299.11 | $295.34 | $298.66 | 945 487 |
| 2023-05-25 | $298.51 | $298.88 | $291.64 | $297.13 | 1 047 755 |
| 2023-05-24 | $301.82 | $302.31 | $298.33 | $301.56 | 842 238 |
| 2023-05-23 | $305.23 | $306.87 | $302.33 | $303.15 | 762 713 |
| 2023-05-22 | $309.93 | $310.47 | $306.13 | $306.87 | 512 654 |
| 2023-05-19 | $307.00 | $310.50 | $306.52 | $308.48 | 492 011 |
| 2023-05-18 | $305.85 | $306.23 | $301.94 | $305.45 | 597 635 |
| 2023-05-17 | $308.25 | $308.25 | $302.15 | $306.25 | 535 782 |
| 2023-05-16 | $310.60 | $310.64 | $306.29 | $307.61 | 624 890 |
| 2023-05-15 | $310.00 | $312.48 | $309.15 | $311.87 | 495 751 |
| 2023-05-12 | $310.97 | $311.35 | $307.70 | $309.60 | 435 733 |
| 2023-05-11 | $313.50 | $313.59 | $308.65 | $310.56 | 697 297 |
| 2023-05-10 | $315.19 | $315.78 | $310.74 | $313.26 | 706 479 |
| 2023-05-09 | $311.87 | $315.69 | $311.09 | $314.00 | 906 111 |
| 2023-05-08 | $317.48 | $317.48 | $310.10 | $314.37 | 936 063 |
| 2023-05-05 | $313.81 | $319.74 | $310.67 | $318.06 | 1 606 111 |
| 2023-05-04 | $311.42 | $314.37 | $309.59 | $313.57 | 1 170 394 |
| 2023-05-03 | $315.00 | $316.69 | $309.55 | $311.00 | 2 708 232 |
| 2023-05-02 | $309.20 | $311.89 | $305.26 | $309.28 | 1 065 426 |
| 2023-05-01 | $305.75 | $312.20 | $304.26 | $311.11 | 1 223 479 |
| 2023-04-28 | $293.91 | $305.50 | $293.62 | $304.23 | 1 927 370 |
| 2023-04-27 | $288.00 | $294.09 | $285.55 | $293.72 | 1 433 807 |
| 2023-04-26 | $278.59 | $289.17 | $274.90 | $288.04 | 1 801 258 |
| 2023-04-25 | $291.05 | $293.97 | $280.72 | $282.41 | 1 494 172 |
| 2023-04-24 | $293.99 | $295.25 | $292.17 | $293.03 | 947 274 |
| 2023-04-21 | $290.60 | $294.19 | $289.51 | $293.99 | 847 810 |
| 2023-04-20 | $290.24 | $291.58 | $289.26 | $290.27 | 653 454 |
| 2023-04-19 | $292.69 | $293.85 | $291.98 | $292.27 | 492 368 |
| 2023-04-18 | $292.36 | $294.62 | $290.07 | $293.83 | 668 884 |
| 2023-04-17 | $294.00 | $294.22 | $290.05 | $292.20 | 764 866 |
| 2023-04-14 | $288.55 | $289.39 | $285.05 | $288.13 | 571 403 |
| 2023-04-13 | $286.26 | $290.90 | $285.45 | $289.70 | 715 483 |
| 2023-04-12 | $284.57 | $287.09 | $283.60 | $285.79 | 611 236 |
| 2023-04-11 | $283.32 | $285.47 | $282.49 | $283.69 | 556 081 |
| 2023-04-10 | $285.40 | $285.65 | $280.29 | $282.86 | 475 778 |
| 2023-04-06 | $285.06 | $287.77 | $283.80 | $286.80 | 737 066 |
| 2023-04-05 | $276.00 | $285.36 | $275.33 | $283.99 | 1 008 171 |
| 2023-04-04 | $277.11 | $277.58 | $273.39 | $275.25 | 579 239 |
| 2023-04-03 | $276.34 | $279.07 | $275.68 | $277.34 | 772 839 |
| 2023-03-31 | $275.44 | $279.00 | $275.44 | $278.03 | 1 196 977 |
| 2023-03-30 | $275.73 | $276.38 | $272.64 | $275.13 | 714 017 |
| 2023-03-29 | $271.12 | $274.62 | $270.89 | $274.01 | 772 863 |
| 2023-03-28 | $270.06 | $271.90 | $268.78 | $270.25 | 560 270 |
| 2023-03-27 | $270.81 | $272.43 | $269.48 | $269.98 | 606 306 |
| 2023-03-24 | $265.44 | $271.36 | $263.15 | $270.03 | 973 373 |
| 2023-03-23 | $262.84 | $267.45 | $262.50 | $265.17 | 703 685 |
About Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
